Goal and Learning Outcomes

The goal of this course is to provide nurses with a step-by-step approach to rhythm analysis and interpretation to enhance their ability to recognize and interpret cardiac dysrhythmias. After studying the information presented here, you will be able to:
  • Describe the components of the cardiac conduction system, incorporating cardiac anatomy and physiology.
  • Interpret and analyze ECG strips and determine rate, regularity, and rhythm.
  • Identify rhythms originating in the sinus node and atria, atrioventricular (AV) node, and ventricles, and discuss their significance and treatment.
  • Recognize Type I, II, and III AV blocks and discuss their significance and treatment.
  • Identify potentially life-threatening rhythms and discuss initial interventions/approach to treatment.
  • Explain the relationship between coronary blood flow, myocardial infarction, and associated ECG findings.

Course Authors

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.